The Business Research Company published its
Viral Vectors and Plasmid DNA Global Market Report 2020 which provides
strategists, marketers and senior management with the critical information they
need to assess the global viral vectors and plasmid DNA market. The report
covers the viral vectors and plasmid DNA market’s segments- by product: plasmid
DNA, viral vectors and by applications: gene and cancer therapies, viral
infections, immunotherapy, formulation development, others.
View Complete Report: https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-market-global-report-2020-30-covid-19-implications-and-growth
Viral Vectors and Plasmid DNA Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing. The major regions included in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
In January 2020, Cognate Bioservices Inc, a
US-based company skilled in cell and cell-mediated gene therapy products,
acquired Cobra Biologics, specialized in providing manufacturing services for
plasmid DNA and viral vector, for an undisclosed amount. The acquisition is
expected to create a platform for the life cycle management of cell and gene therapy
products. Cobra biologics is well established in the development and
manufacture of a variety of viral vectors and DNA. The combined Cognate and
Cobra expertise is expected to push both the businesses to a better position to
respond to current and future market demand.
Few
Points From Table Of Content:
1. Executive Summary
2. Viral Vectors and Plasmid DNA Market Characteristics
3. Viral Vectors and Plasmid DNA Market Size And Growth
4. Viral Vectors and Plasmid DNA Market Segmentation
5. Viral Vectors and Plasmid DNA Market Regional And Country
Analysis
…...
25. Viral Vectors and Plasmid DNA Market Competitive Landscape And
Company Profiles
26. Key Mergers And Acquisitions In The Viral Vectors and Plasmid
DNA Market
27. Viral Vectors and Plasmid DNA Market Trends And Strategies
28. Viral Vectors and Plasmid DNA Market Future Outlook and
Potential Analysis
29. Appendix
https://www.thebusinessresearchcompany.com/sample.aspx?id=3245andtype=smp
Few Points from List Of Tables
Table 1: Global Historic Market Growth,
2015-2019, $ Billion
Table 2: Global Forecast Market Growth,
2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 3: Global Viral Vectors and Plasmid
DNA Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F,
2025F, 2030F, $ Billion
Table 4: Global Viral Vectors and Plasmid
DNA Market, Segmentation By Applications, Historic and Forecast, 2015-2019,
2023F, 2025F, 2030F, $ Billion
Table 5: Global Viral Vectors and Plasmid
DNA Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F,
2030F, $ Billion
………
Table 45: FUJIFILM Diosynth Biotechnologies
Financial Performance
Table 46: FinVector Vision Therapies
Financial Performance
Table 47: Lonza Financial Performance
Table 48: Cobra Biologics and
Pharmaceutical Services Financial Performance
Table 49: Brammer Bio Financial Performance
About
The Business Research Company:
The Business Research Company is a Business Intelligence Company
which excels in company, market and consumer research. It has offices in the
UK, the US and India and a network of trained researchers in 52 countries
globally.
Contact
Information:
The
Business Research Company
Europe:
+44 207 1930 708
Asia:
+91 8897263534
Americas:
+1 315 623 0293
Email:
info@tbrc.info
No comments:
Post a Comment